ORASURE TECHNOLOGIES, INC.
BETHLEHEM, PA

OraSure Technologies, Inc. is a distinguished biotechnology company renowned for its advanced products marketed in over 40 countries globally. The company specializes in offering comprehensive sexual health and infectious disease testing solutions, employing a global outreach strategy through strategically selected distributors. OraSure prides itself on providing exceptional service, support, and training to ensure customer satisfaction and effective product implementation. Headquartered with legal ties to both Florida (Registered address) and Pennsylvania (Mailing address), this company operates as a Foreign Profit Corporation ('FORP') since its incorporation date of September 6, 2001. Although incorporated in Pennsylvania as seen from the provided mailing address at 220 East First Street, Bethlehem, PA 18015, its registered state for corporate filings is Florida. OraSure Technologies maintains a comprehensive suite of contact numbers to facilitate smooth customer service and inquiries alongside a robust digital presence via its website: [orasuretechnologies.com](http://orasuretechnologies.com). Under the leadership of CEO Carrie Eglinton Manner, the company has demonstrated steadfast commitment towards innovation and excellence within its industry. Its governance includes other key officers like Michele Anthony serving as Senior and Stefano Taucer in a secretarial capacity. The firm's recent corporate milestones include a reconstitution event on April 16, 2013, reaffirming its ongoing compliance and operational status, with the latest annual report recorded for the year 2024. The Federal Employer Identification Number (FEI) attributed to OraSure is 364370966.